Valentia Lee-Brotherton, Ph.D., Vice President, Pharmaceuticals & Healthcare
Dr. Valentia Lee-Brotherton has been with Intertek for over 20 years. She has worked in a range of therapeutic areas and collaborated closely with clients to move their drug development projects forward with efficiency and expediency. As a senior toxicologist, she is involved in the strategic planning, design, and implementation of product development programs, including early-stage IND or CTA investigational products as well as those that are nearing registration. She provides experienced authorship and review of regulatory documents of various types, including Investigator’s Brochures, INDs, CTAs, Responses to Health Authority comments, and registration dossiers. Using her many years of experience across a broad variety of programs, she guides companies through pathways to overcome potential roadblocks and supports them through their meetings and other interactions with regulators.
Over the years, Dr. Lee-Brotherton has enjoyed long working relationships with many clients. Using a team approach, she creatively and responsively provides advice and resolves toxicology and regulatory affairs issues for clients so that they can successfully reach their product development milestones.
